3-Dimension Conformal Technology Guided Radiofrequency Ablation of liver’s left lobe for Intrahepatic Cholangiocarcinoma: A Case Report

doi:10.3877/cma.j.issn.2095-5782.2014.03.018

Abstract

Abstract:

Hepatocellular carcinoma and cholangiocarcinoma are the two most common malignant liver tumors.The prognosis for patients with untreated unresectable cholangiocarcinoma is depressed,especially to the patient with invasion in the portal vein. It has no effective treatment presently. Radiofrequency ablation (RFA) plays an importmant role in the treatment of unresectable liver tumors.It is considered a viable alternative to surgery for inoperable patients. Here,we report the successful use of CT- guided RFA in a patient with intrahepatic Cholangiocarcinoma with invasion in the portal vein.The patient survived for 26 months.

Key words: intrahepatic cholangiocarcinoma, tumor thrombus, radiofrequency ablation

Jiasheng Zheng, Caixia Hu, Bin Sun. 3-Dimension Conformal Technology Guided Radiofrequency Ablation of liver’s left lobe for Intrahepatic Cholangiocarcinoma: A Case Report[J]. Chinese Journal of Interventional Radiology(Electronic Edition), 2014, 02(03): 65-67.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhjrfsxdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-5782.2014.03.018

https://zhjrfsxdzzz.cma-cmc.com.cn/EN/Y2014/V02/I03/65

Figures/Tables 5

References 18

1	Park J,Kim MH,Kim KP, et al. Natural history and prognostic factors of advanced cholangiocarcinoma without surgery, chemotherapy, or radiotherapy: a large-scale observational study. Gut Liver 2009;3 :298-305
2	Burger I,Hong K,Schulick R, et al. Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience in a single institution. J Vasc Interv Radiol2005 ;16 :353-361
3	Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology. 2001;33:1353-1357.
4	Taylor-Robinson SD,Toledano MB,Arora S, et al. Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales, 1968-1998. Gut. 2001;48:816-820.
5	Davila JA,El-Serag HB. Cholangiocarcinoma: the "other " liver cancer on the rise. Am J Gastroenterol. 2002;97:3199-3200.
6	de Groen PC,Gores GJ,LaRusso NF, et al. Biliary tract cancers. N Engl J Med. 1999;341:1368-1378.
7	Park J,Kim MH,Kim KP, et al. Natural history and prognostic factors of advanced cholangiocarcinoma without surgery, chemotherapy, or radiotherapy: a large-scale observational study. Gut Liver 2009;3 :298-305
8	Burger I,Hong K,Schulick R, et al. Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience in a single institution. J Vasc Interv Radiol2005 ;16 :353-361
9	Nakeeb A,Tran KQ,Black MJ, et al. Improved survival in resected biliary malignancies. Surgery 2002;132 :555-563
10	Ben-Menachem T. Risk factors for cholangiocarcinoma. Eur. J. Gastroenterol. Hepatol.2007, 19, 615–617
11	Blechacz B. R., Gores G. J.Cholangiocarcinoma. Clin. Liver Dis. 2008,12, 131–150,
12	El-Serag H. B., Engels E. A., Landgren O., Chiao E., Henderson L., Amaratunge H. C., Giordano T. P.Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: a population-based study of U.S. veterans. Hepatology,2009, 49, 116–123
13	Aljiffry M,Walsh MJ,Molinari M. Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990–2009. World J Gastroenterol 2009;15 :4240-4262
14	De Baere T,Deschamps F,Briggs P, et al. Hepatic malignancies: percutaneous radiofrequency ablation during percutaneous portal or hepatic vein occlusion. Radiology 2008;248 :1056-1066
15	Cho YK,Kim JK,Kim MY,Rhim H,Han JK. Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies. Hepatology 2009;49 :453-459
16	Stang A,Fischbach R,Teichmann W,Bokemeyer C,Braumann D. A systematic review on the clinical benefit and role of radiofrequency ablation as treatment of colorectal liver metastases. Eur J Cancer 2009;45 :1748-1756
17	Meloni MF,Andreano A,Laeseke PF,Livraghi T,Sironi S,Lee FT Jr. Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation—intermediate and long-term survival rates. Radiology 2009;253 :861-869
18	Fujii T,Takayasu K,Muramatsu Y,Moriyama N,Wakao F,Kosuge T, et al. Hepatocellular carcinoma with portal tumor thrombus: analysis of factors determining prognosis. Jpn J Clin Oncol 1993;23:105–9.

[1]	Peng Tu, Xiaohang Zhang, Hongmei Dong, Gongli Chen, Suzhen Ran. Application value of ultrasound Doppler after radiofrequency ablation and fetal reduction for twin-to-twin transfusion syndrome [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(05): 492-497.
[2]	Lin Yan, Yu Lan, Fang Xie, Yukun Luo. Long-term clinical outcomes of ultrasound-guided radiofrequency ablation for low-risk papillary thyroid microcarcinoma [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(02): 227-231.
[3]	Jinlong Zhou, Junjie Liu, Hao Gu. Prognostic value of lymph node dissection for intrahepatic cholangiocarcinoma: A meta-analysis [J]. Chinese Archives of General Surgery(Electronic Edition), 2023, 17(02): 155-160.
[4]	Xing Wang, Fengwei Zhang. Clinical study of laparoscopic hepatectomy combined with radiofrequency ablation in the treatment of hepatocellular carcinoma with microvascular invasion [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(05): 580-583.
[5]	Xiaolong Huang, Shibu Lin, Lin Han, Youke Chen, Yan Yang. Prognostic study of radical resection of intrahepatic cholangiocarcinoma with different lymph node dissection ranges [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(04): 401-404.
[6]	Mingjie Song, Qinglei Han, Jialong Li, Yingmei Shao. Current status of endoscopic ablation for advanced extrahepatic bile duct malignancies [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(03): 340-342.
[7]	Guoliang Li, Fan Wu, Haomin Li, Junbin Jiang, Zexiong Guo, Yumin Zhuo, Xin Ma, Caiyong Lai. Application of thrombus aspiration in total laparoscopic thrombectomy in treatment of left renal cell carcinoma with level Ⅳ inferior vena cava thrombus [J]. Chinese Journal of Endourology(Electronic Edition), 2023, 17(04): 403-406.
[8]	Haitao Zhang, Zhe Jia, Chao Ma, Qikun Zhang, Jushan Wu, Qingliang Guo, Daobing Zeng, Guangming Li, Menglong Wang. Comparison of clinical efficacy of liver resection and radiofrequency ablation for peripheral single small hepatocellular carcinoma [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(05): 523-527.
[9]	Binkui Li. Conversion therapy for unresectable intrahepatic cholangiocarcinoma [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(05): 511-516.
[10]	Hongyu Meng, Yi Lu, Yanlong Cao, Cao Dai, Jiawei Yang, Nan Lin, Jianliang Xu. Comparison of therapeutic effect between TACE combined with radiofrequency ablation and radiofrequency ablation alone for small liver cancer based on propensity score matching [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(04): 417-421.
[11]	Facai Yang, Chuan You, Zhengqing Lei, Weinan Li, Anqi Duan, Yinghe Qiu, Jingdong Li, Zhangjun Cheng. Predictive value of tumor burden score combined with lymph node staging for postoperative survival of intrahepatic cholangiocarcinoma patients [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(04): 389-394.
[12]	Chengyu Liao, Binhua Jiang, Long Huang, Danfeng Wang, Yifeng Tian, Shi Chen. Application value of modified three-step technique in laparoscopic radical resection of intrahepatic cholangiocarcinoma of left lobe [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(04): 395-400.
[13]	Yanbin Yu, Shouqin Dang, Yunlong Zhuang, Shiyou Xu, Lingzhan Meng, Peng Yu, Yuan Gao, Hu Li, Li Cao, Zhenyu Zhu. Diagnosis, treatment and efficacy of 35 patients with hepatic angiomyolipoma [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(03): 327-330.
[14]	Xiaopeng Yu, Chen Chen, Jialu Chen, Huanjun Tong, Yinghe Qiu, Hong Wu, Tianqiang Song, Yu He, Xianhai Mao, Wenlong Zhai, Zhangjun Cheng, Jingdong Li, Zhimin Geng, Zhaohui Tang. Preoperative clinicopathological features of patients obtaining survival benefit from lymph node dissection in intrahepatic cholangiocarcinoma resection [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(03): 278-283.
[15]	Tianqing Wu, Jiongliang Wang, Zhikai Zheng, Wenxuan Li, Zhongguo Zhou. Efficacy and safety of transarterial radioembolization for unresectable intrahepatic cholangiocarcinoma: a Meta-analysis [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(02): 190-195.

Please choose a citation manager

Content to export